Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.
Fernández, Javier
Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. [electronic resource] - Hepatology (Baltimore, Md.) Jan 2002 - 140-8 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0270-9139
10.1053/jhep.2002.30082 doi
Aged
Anti-Infective Agents--therapeutic use
Bacterial Infections--epidemiology
Critical Care
Drug Resistance, Microbial
Escherichia coli--isolation & purification
Female
Gram-Negative Bacteria
Gram-Positive Cocci
Hepatitis C
Humans
Kidney--physiopathology
Liver--physiopathology
Liver Cirrhosis--microbiology
Liver Cirrhosis, Alcoholic--microbiology
Male
Middle Aged
Norfloxacin--therapeutic use
Peritonitis--microbiology
Prospective Studies
Sulfamethoxazole--therapeutic use
Trimethoprim--therapeutic use
Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. [electronic resource] - Hepatology (Baltimore, Md.) Jan 2002 - 140-8 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0270-9139
10.1053/jhep.2002.30082 doi
Aged
Anti-Infective Agents--therapeutic use
Bacterial Infections--epidemiology
Critical Care
Drug Resistance, Microbial
Escherichia coli--isolation & purification
Female
Gram-Negative Bacteria
Gram-Positive Cocci
Hepatitis C
Humans
Kidney--physiopathology
Liver--physiopathology
Liver Cirrhosis--microbiology
Liver Cirrhosis, Alcoholic--microbiology
Male
Middle Aged
Norfloxacin--therapeutic use
Peritonitis--microbiology
Prospective Studies
Sulfamethoxazole--therapeutic use
Trimethoprim--therapeutic use